The possibility that cortical spreading depres sion (CSD) may have neuroprotective action during sub sequent focal cerebral ischemia was examined in rats. Three days before the imposition of focal cerebral isch emia CSDs were elicited by applying potassium chloride (KC!) for 2 h through a microdialysis probe implanted in the occipital cortex. Control animals were handled iden tically except that saline was infused instead of KCI. Fo cal ischemia was produced by the intraluminal suture method and cortical and subcortical infarct volumes were measured 7 days later. Neocortical infarct volume was reduced from 124. 8 ± 49. 5 mm 3 in the controls to 62.9 ± Abbreviations used: CSD, cortical spreading depression; GFAP, glial fibrillary acidic protein; MCAO, middle cerebral artery occlusion; VSCC, voltage-sensitive calcium channel.
Cortical spreading depression (CSD) is character ized by a propagating wave of depressed electrical activity and cell membrane depolarization. It can be elicited by a variety of means including a stab wound, ischemia, raised extracellular potassium, and strong electrical stimulation. It is also known that periinfarct depolarization occurs in cortical tis sue surrounding an acute ischemic lesion (Neder gaard and Astrup, 1986) . Because CSD is a process that leads to substantial activation of energy requir ing metabolism (Csiba et al., 1985; Kocher, 1990; Mayevsky and Weiss, 1991) , its occurrence in the peripheral zone of an occluded cerebral artery is considered harmful because it can add metabolic stress to the periinfarct region and tip the balance in favor of cell death instead of reversible injury. Recently, Mies et al. (1993) and Chen et al. (1993) have reported that the number of peri infarct depo-59.5 mm 3 in the animals preconditioned with CSD (p = 0.012). There was no difference between the two groups in the subcortical infarct volume or in CBF, measured by the hydrogen clearance method, during or immediately after the ischemic interval. Our data indicate that precon ditioning CSD applied 3 days before middle cerebral ar tery occlusion may increase the brain's resistance to focal ischemic damage and may be used as a model to explore the neuroprotective molecular responses of neuronal and glial cells. Key Words: Cortical spreading depression N europrotection-Focal cerebral ischemia-Rat Preconditioning.
larization events correlates with the volume of in farct. Two lines of evidence have led us to test CSD's potential as a neuroprotective maneuver in isch emia. First, it is now clear that brief episodes of ischemic pretreatment can increase the brain's tol erance to a subsequent ischemic event (Kato et al., 1991; Kirino et aI., 1991) . Matsushima and Hakim (1995) have recently confirmed these find ings and showed that this phenomenon referred to as ischemic preconditioning, is not associated with changes in rCBF. This suggests that the neuropro tective response is acquired through molecular up regulation of the brain's ability to resist ischemic injury. Second, we have shown that CSD is associ ated with a moderate increase in the binding of [3H]nimodipine to brain, consistent with the activa tion of voltage-sensitive calcium channels (VSCC) (Osuga et aI., 1993) . This activation implies limited intracellular influx of calcium ions, which act as second messengers but may be reexported after in ducing a number of molecular responses (Kiessling et aI., 1993) . Thus, we speculated that CSD could be used as a preconditioning treatment and lead to increased resistance to ischemic damage. Recently, Kawahara et al. (1994) reported that rats subjected to CSD had significantly less damage to hippocam pal CAl neurons after cardiac arrest cerebral isch emia, but this is the first report of CSD used as a preconditioning maneuver for subsequent focal ce rebral ischemia. Our data show that preconditioning with CSD could attenuate the outcome from such ischemia, and that this neuroprotective effect is not mediated through a change in rCBF during isch emia.
MATERIALS AND METHODS

Experimental design
Two groups were prepared. The "CSD + ISO-min mid dle cerebral artery occlusion (MCAO) group" (n = 14) had left MCA occlusion lasting ISO min imposed 3 days after a 2-h episode of ipsilateral cortical spreading depres sion. CSDs were produced by perfusing KCI into the left occipital cortex. The other group (n = 14), labeled "sham + 180 min MCAO group," was subjected to a similar duration of MCA occlusion after perfusion with normal saline for 2 h instead of KCI. DC potentials were recorded from two platinum electrodes implanted bilaterally in the frontal cortex during the instillation of KCl or saline as well as during the MCA occlusion. Thus, the two groups were compared for the number of CSD waves, rCBF dur ing MCA occlusion, and histological outcome.
Surgical and experimental procedures
Twenty eight male Sprague Dawley rats weighing 260-300 g were used. Instruments used during surgery were autoclaved and all implanted probes were sterilized in 70% ethanol solution. The surgery was performed under sterile conditions. During the induction of CSD and in controls, rats were intubated and ventilated mechanically with I % halothane in a mixture of 30% oxygen-70% ni trous oxide. The tail artery was cannulated with a poly ethylene catheter for monitoring of arterial blood pres sure, blood gases, and blood glucose. All procedures fol lowed the guidelines of the Canadian Council on Animal Care (Guide to the Care and Use of Experimental Ani mals), and were approved by the University of Ottawa Animal Care Committee. The rats were then put in the stereotaxic frame (Kopf Instruments, Tujunga, CA, U.S.A.) and four small burr holes were made over the left frontal, frontoparietal, and occipital cortex and over the right frontal cortex. Three platinum electrodes (0.1 mm in diameter) were implanted: in the left frontoparietal cortex (bregma -1.5 mm; lateral 4.0 mm, depth 2.0 mm) for subsequent measurement of rCBF by the hydrogen clear ance method, in the left frontal cortex (bregma 2.0 mm; lateral 6.0 mm; depth 2.0 mm) and the right frontal cortex (bregma 1.5 mm; lateral 5.0 mm; depth 2.0 mm) for re cording of CSD and fixed with dental cement. A platinum wire reference electrode was inserted into the auricle of the right ear and both electrodes were connected to a DC amplifier and a chart recorder (WindoGraf Recorder, Gould Instruments Inc., Valleyview, OH, U.S.A.). A mi crodialysis probe (diameter 0.5 mm, active length 1.0 mm, CMA-12; CMA/Microdialysis AB, Sweden) was in serted stereotaxically into the left occipital cortex (bregma -7.8 mm; lateral 6.0 mm; depth 2.0 mm) and also fixed with dental cement. Accordingly, the recording of the CSD waves occurred 9.8 mm from the microdial ysis instillation of KCI. Recording of CSD was started at the same time as implantation of a microdialysis probe to record any elicitation of CSD by the probe insertion itself. Recurrent waves of CSD were induced by perfusion with 3 M KCI through the microdialysis probe at the rate of 2.0 f,Ll/min. In a separate study, using an Ag/AgCI agar bridge electrode, it was confirmed that deflections recorded by the platinum electrode corresponded to DC potential shift. After 2 h, CSD was stopped by flushing the microdi alysis probe with normal saline. The rats were allowed to recover from anesthesia and returned to their cages.
Three days later, rats were again anesthetized with 1% halothane in a mixture of 30% oxygen-70% nitrous oxide. The right femoral artery was cannulated with a polyeth ylene catheter for monitoring of physiological parame ters, and focal cerebral ischemia was induced by the in traluminal occlusion method using a nylon monofilament thread (Longa et aI., 1989) . Briefly, the left common, ex ternal, and internal carotid arteries were carefully ex posed after a ventral midline incision in the neck. The distal portions of the left external carotid and ipsilateral common carotid arteries were ligated with 4-0 silk suture. Immediately after that, a 3-0 nylon monofilament thread was introduced through the ipsilateral common carotid artery, distal to the ligation, into the internal carotid ar tery. After introducing this occluder thread, the common carotid artery just distal to the point of insertion was li gated to pre,>;,ent bleeding and the tip of the occluder thread was advanced 18.5 mm distal to the carotid bifur cation. The occlusion of the MCA was confirmed by mea suring rCBF using the hydrogen clearance method, and the number of periinfarct depolarization waves was re corded in each animal. For measurement of rCBF, the platinum electrode implanted previously was polarized to + 500 m V relative to an Agi AgCl reference inserted under the scalp using a H2 clearance amplifier (Computer Tech nology Centre, The University of Virginia). Then, -10% hydrogen gas was added to the inhaled gas mixture. In halation of hydrogen gas was stopped after reaching sat uration level and the hydrogen clearance curve was re corded (WindoGraf Recorder, Gould Instruments Inc.). rCBF was measured hourly during ischemia and immedi ately after release of the MCA occlusion. The thread was withdrawn 3 h after induction of ischemia. The suture over the external carotid was released and reperfusion was again confirmed by measuring rCBF. The wound was then sutured with topical instillation of Xylocaine jelly, anesthesia was discontinued and the rat was allowed free access to food and water until the next procedure. During MCA occlusion, rectal and temporal muscle tempera tures, MABP, arterial blood gases, plasma pH, and the plasma glucose concentration were monitored.
Seven days after MCA occlusion, the rats were decap itated while they were under the same anesthetic condi tion and the brains were removed and frozen in methyl butane cooled by liquid nitrogen and processed for histo logic assessment. Brain sections, 20 f..L m thick, were stained with cresyl violet. The infarct areas in 15 brain sections that were equally spaced along the brain's entire anterior-posterior axis were measured by a microcom puter-based image display system (MCID, Imaging Re search Inc., St. Catharines, Ontario, Canada) using the method described by Swanson et al. (1990) . Infarct vol ume was calculated as the integral of the infarct areas for the cortex and the striatum separately. In measuring the latter, white matter fascicles passing through the basal ganglia were not counted.
Statistical analysis
All data were expressed as mean ± SD. Comparison of physiologic parameters, rCBF, and total infarct volumes between groups was done using independent t tests. Lin ear regression was used to correlate infarct volume with rCBF and the number of periinfarct depolarizations. The effect of prior conditioning with CSD on infarct volumes was assessed using analysis of covariance with rCBF as the covariate.
RESULTS
Physiological variables
During 2 h of KCl application and MCA occlu sion, MABP, rectal and temporalis muscle temper atures, blood glucose concentration, hematocrit, and blood gases were not statistically different be tween the two groups and are given in Table I .
KCl-elicited CSD and periinfarct depolarization
No CSD waves were observed on implantation of the microdialysis probe in the CSD + ISO-min MCAO or the sham + ISO-min MCAO groups. In the CSD + ISO-min MCAO group, CSD waves were recorded during 2 h of KCl instillation as a transient negative shift of DC potential. The waves had an amplitude of 4.9 ± I.S m V and a duration of S1.7 ± 10.4 s consistent with previously reported characteristics of CSD (McLachlan, 1992; Somjen et aI., 1992) . The number of CSD waves recorded in the left frontal cortex of CSD + ISO min MCAO group during 2 h was 11.5 ± 4.2. In the sham + ISO-min MCAO group perfused with normal saline, no CSD was observed during 2 h. No CSD waves were recorded in the contralateral frontal cortex during perfusion with KCl or normal saline. The number of periinfarct depolarization events re corded during MCA occlusion was 4.1 ± 7.9 and 1.6 ± 1.6 in the groups without and with precondition-ing CSD, respectively, without significant differ ence. One rat in the sham + ISO-min MCAO group had 27 periinfarct depolarization events during 3 h of MCA occlusion. The number of periinfarct depo larization events excluding this rat was similar in the two groups (1.S ± 2.1 versus 1.6 ± 1.6 in the sham and CSD groups, respectively). rCBF rCBF during MCA occlusion showed no signifi cant difference between the two groups (Fig. 1) . Mean rCBF during MCA occlusion was 17.2 ± 2.9 and 17.0 ± 4.2 mill 00 g/min in the groups without and with preconditioning CSD, respectively. Imme diately after release of MCA occlusion, mean rCBF values were also not statistically different between the two groups.
Survival and histologic outcomes
One animal in the CSD + ISO-min MCAP group died immediately after the removal of the occluder thread from a subarachnoid hemorrhage. Three an imals in the sham + ISO-min MCAO group also died: one at the same time point as already men tioned, and two within 2 days of MCAO from mas sive cerebral edema. Thus the analysis was per formed on n = 13 for the CSD + ISO MCAO group and n = 11 for the sham + MCAO group.
In the CSD + ISO-min MCAO group, a zone of tissue necrosis, �0.5 mm deep, surrounded the mi crodialysis probe. No such necrosis was evident in the control groups.
Infarction was noted in the neocortex and stria tum in both groups (Table 2) . Total cortical infarct volumes were 124.S ± 49.5 and 62.9 ± 59.5 mm3 in the groups without and with the preconditioning CSD (p = 0.012) indicating that this maneuver sig nificantly reduced total cortical infarct volume. In farct volumes for the striatum were 13.7 ± 4.5 and 15.0 ± 5.5 mm3 in the groups without and with the Values are means ± SD. MCAO, middle cerebral artery occlusion; CSD, cortical spreading depression; NS, normal saline; Ht, hematocrit. 
.... Values are means ± SO.
preconditioning CSD, respectively, with no signifi cant difference (p = 0.56). Figure 2 shows the re lationship between histologic outcomes and CBF in individual animals. In the sham + 180-min MCAO group, cortical infarct volumes appeared to increase linearly with decreasing rCBF (r = 0.7, p = 0.016), whereas in the CSD + 180-min MCAO group, cor tical infarct volume remained low until rCBF fell below 14 mlll00 g/min. If the infarct volume data for the CSD + I80-min MCAO group were fit linearly against rCBF, a significant correlation did result (r 0.6, p = 0.024). The difference in these correla- tions was highly significant (FO,2 1 ) = 12.83, P = 0.0018 by one-way analysis of covariance) with CSD pretreatment resulting in reduced cortical in farct volumes over a range of rCBF values. Below an rCB F of � 14 ml 100 g -1 Imin -1 , both groups developed large cortical infarcts. Figure 3 shows that there is no correlation be tween the number of periinfarct depolarization waves during 3 h of MCAO and histological out come.
DISCUSSION
The data presented here suggest that CSD can attenuate subsequent ischemic cerebral damage. Cerebral blood flows measured in the area sur- rounding the ischemic core were not significantly different between the group that had received and the one without preceding CSD, suggesting that the attenuation in ischemic damage is not related to im proved perfusion. Two constraints seemed to ap ply: The beneficial effect of the preceeding CSD was limited to the neocortex, and rCBF had to re main > 14 ml 100 g -I Imin -I for a neuroprotective effect from CSD to become evident. This would indicate that preconditioning with CSD is likelyef rectjye only in E.enumb � l tissue. The experimental resign limits our conclusIOns at other ways. In our �perjments ��� � �i �� interval (3 dayVe !;yeen CSD ;t1fi ;;;;;; ; i:;m � d. ThIS was chosen because ischemic preconditIOning studies in global ischemia indicated that this was an effective interval (Kirino et al., 1991) . The 180-min duration of MCAO was chosen because it caused both sub cortical and cortical damage with minimum variabil ity (Memezawa et al., 1992) . The duration of CSD selected was sufficiently long to permit effective preconditioning, but other durations may have been more or less neuroprotective. In this study, a platinum wire electrode was used for DC potential measurement. This electrode may not be ideal, but the waveforms recorded were con sistent with previously reported characteristics of CSD (McLachlan, 1992; Somjen et al., 1992) . CSD may be generated by insertion of the electrode itself (Verhaegen et al. , 1992) and by the microdialysis probe (Tomida et al., 1989) , but this would have affected both groups equally. In fact, no CSDs were recorded during the microdialysis probe implanta tion in any animals. This may be due to the fact that our recording electrode was 8. 9 mm from the mi crodialysis probe.
In our study, the mean number of periinfarct de uolarization waves was not statistically dIff erent be tween the two groups and no correlation between the number of periinfarct depolarizatIOn waves ana Infarct volUme was eVIdent (Fig. 3) . Because CSD leads to activatIOn of energy-requiring metabolism (Csiba et al., 1985; Kocher, 1990; Mayevsky and Weiss, 1991) , it is supposed that CSD-like periin farct depolarization events may lead to temporary energy deficits that endanger the brain tissue in the border zone of cerebral infarct. In this regard, Mies et al. (1993) and Chen et al. (1993) demonstrated that the number of periinfarct depolarization events correlates with the volume of infarct. Our data do not support this, which might be due to differences in the ischemic model, the duration of ischemia, or technical factors such as the sites of recording. De spite these limitations, our results suggest that de creasing cortical infarct volume is possible through preceding CSD, supporting the data of Kawahara et al. (1994) , who reported that rats subjected to CSD 3 days before cardiac arrest cerebral ischemia had significantly reduced damage to CAl neurons of the hippocampus. The combined information implies that the neuroprotective effect of prior CSD ex tends beyond the cortex to involve the hippocam pus but does not reach the striatum.
The mechanisms of neuroprotection induced by CSD can only be speculated on. We have shown that CSD elicits the activation of VSCC, implying influx of calcium ions into neuronal cells (Osuga et al., 1993) . VSCC activation mediates the induction of a variety of immediate early genes (Murphy et al. , 1991) which may regulate neuronal gene expres sion (Dragunow et al., 1989; Hengerer et al., 1990; Sheng and Greenberg, 1990) . The level of brain derived neurotrophic factor mRNA rapidly in creases in cortical neurons after CSD (Kokaia et al., 1993) . Herrera and Robertson (1990) showed that the application of KCI to the brain surface elicits the induction of c-fos and nerve growth factor mRNA in the treated cerebral hemisphere. This preceded an increase in FOS immunoreactivity and nerve growth factor-like protein (Herrera et al., 1993) . In addition, there is evidence that CSD can affect glial as well as neuronal gene expression. KCI applica tion to the brain surface leads to an increase in glial fibrillary acidic protein (GFAP) mRNA level (Bonthius et al., 1993 (Bonthius et al., , 1994 and GFAP immunore activity throughout the treated cerebral cortex (Kraig et al. , 1991) . An increase in GFAP immuno reactivity denotes the transformation of normal as trocytes to reactive ones that can secrete neu ronotrophic factors, which in turn may promote the growth and survival of injured neurons (Bignami and Dahl, 1976; Nieto-Sampedro et al., 1982; Need els et al., 1986) . Kawahara et al. (1994) also ob served a strong ipsilateral GF AP reaction at 3 days after CSD induction. Thus, CSD induces a number of neuronal and glial genes, which may become templates for proteins that have neuroprotective properties. The one exception to this appears to be heat shock proteins. Nowak et al. (1991) and others more recently (Ikeda et al., 1994; Kawahara et al., 1994) have shown that CSD could not induce heat shock proteins despite the suggestion that they play a role in the acquisition of ischemic tolerance through ischemic preconditioning (Kitagawa et al., 1991) . In conclusion, CSDs appear to be capable of inducing many neuronal and glial neurotrophic and other mRNAs, some of which may be translated into proteins with neuroprotective properties.
It is unlikely that CSD would ever become a clin ically useful means of increasing the brain's resis-tance to subsequent ischemic damage. Rather, CSD provides an experimental tool to understand the re sponses involved in neuroprotection from cerebral ischemia. Further study is needed to clarify the ef fective time window and intensity of CSD as well as the exact mechanism linking CSD to the neuropro tection.
